ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT AUGUST 2025
Zinzino group revenue increased with a total of 38 %, compared with the previous year.
The revenue in August for Zinzino's sales markets increased by 46 % and amounted to SEK 243.6 (167.0) million. Faun Pharma's external sales decreased and amounted to SEK 3.3 (12.2) million. Overall, the Group increased revenues by 38 % to SEK 246.9 (179.2) million compared with the previous year.
Accumulated revenue for January – August 2025 increased by 55 % to SEK 2,028.7 (1,309.9) million.
Revenues were distributed as follows:
|
Regions,MSEK |
25-Aug |
24-Aug |
Change |
YTD 2025 |
YTD 2024 |
Change |
|
The Nordics |
26.3 |
24.0 |
10% |
208.2 |
188.6 |
10% |
|
Central Europe |
72.2 |
45.7 |
58% |
563.9 |
345.7 |
63% |
|
East Europe |
28.8 |
31.0 |
-7% |
246.8 |
251.6 |
-2% |
|
South & West Europe |
40.9 |
32.9 |
24% |
350.0 |
226.5 |
55% |
|
The Baltics |
9.6 |
6.7 |
43% |
76.3 |
62.2 |
23% |
|
North America |
41.1 |
15.6 |
163% |
341.3 |
113.7 |
200% |
|
Asia-Pacific |
22.6 |
9.8 |
131% |
191.6 |
38.0 |
404% |
|
Africa |
2.1 |
1.3 |
62% |
14.1 |
9.7 |
45% |
|
Zinzino |
243.6 |
167.0 |
46% |
1,992.2 |
1,236.0 |
61% |
|
Faun Pharma |
3.3 |
12.2 |
-73% |
36.5 |
73.9 |
-51% |
|
Zinzino Group |
246.9 |
179.2 |
38% |
2,028.7 |
1,309.9 |
55% |
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China, Philippines
-Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, dag@zinzino.com
Fredrik Nielsen CFO Zinzino +46 (0) 707 900 174, fredrik.nielsen@zinzino.com
Pictures for publication free of charge:
marketing@zinzino.com
Certified Adviser:
DNB Carnegie Investment Bank AB (publ.)
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutritional supplements and scientific skincare. The company is publicly listed on Nasdaq First North Premier Growth Market, and its scientifically proven products are available in more than 100 markets worldwide. Zinzino has acquired the assets of the American health and wellness companies Zurvita and Xelliss, is a partner in the Cypriot olive oil producer Cleanthi Alpha-Olenic LTD, and owns the Swiss biotech skincare brand HANZZ+HEIDII. The company also operates Norwegian research and production units BioActive Foods AS and Faun Pharma AS. Zinzino is headquartered in Gothenburg, Sweden, with additional offices across Europe, Asia, and Australia.